Galapagos NV
GLPG
#5074
Rank
โ‚ฌ1.63 B
Marketcap
24,29ย โ‚ฌ
Share price
0.00%
Change (1 day)
-12.75%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚ฌ1.63 Billion

As of July 2026 Galapagos NV has a market cap of โ‚ฌ1.63 Billion. This makes Galapagos NV the world's 5074th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.63 B-11.95%
2025โ‚ฌ1.85 B7.18%
2024โ‚ฌ1.72 B-28.66%
2023โ‚ฌ2.42 B-11.04%
2022โ‚ฌ2.72 B-15.56%
2021โ‚ฌ3.22 B-38.72%
2020โ‚ฌ5.26 B-56.35%
2019โ‚ฌ12.05 B174.87%
2018โ‚ฌ4.38 B9.61%
2017โ‚ฌ4.00 B41.28%
2016โ‚ฌ2.83 B25.66%
2015โ‚ฌ2.25 B380.44%
2014โ‚ฌ0.46 B3.4%
2013โ‚ฌ0.45 B6.23%
2012โ‚ฌ0.42 B55.55%
2011โ‚ฌ0.27 B-14.13%
2010โ‚ฌ0.31 B79.77%
2009โ‚ฌ0.17 B142.03%
2008โ‚ฌ73.5 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ539.05 B 32,942.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ153.45 B 9,306.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ392.03 B 23,930.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ91.82 B 5,528.61%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ275.78 B 16,805.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ230.58 B 14,034.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ89.05 B 5,358.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚ฌ0.10 B-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ30.75 B 1,785.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel